期刊文献+

T细胞亚群、IL-6在IgA肾病患者扁桃体摘除术后的应用价值 被引量:4

The change of peripheral blood T lymphocyte subsets and urine Interleukin-6 in patients of IgA nephropathy with tonsillectomy
暂未订购
导出
摘要 目的探讨IgA肾病患者扁桃体摘除术前后T细胞亚群、IL-6的应用价值。方法伴有扁桃体炎IgAN患者60例,60例健康志愿者作为对照组。流式细胞术检测受试者血液中的T细胞亚群含量,ELISA方法检测受试者尿IL-6水平。结果IgAN患者组扁桃体摘除前尿IL-6水平明显高于健康对照组(p<0.01)。CD4/CD8比值明显低于健康对照组(p<0.01),扁桃体摘除术后IgAN患者尿IL-6水平明显降低,CD4/CD8比值升高,与术前相比有显著性差异(P<0.05)。结论扁桃体摘除术能够明显降低其对IgAN患者的免疫刺激,有助于IgAN患者的恢复。尿IL-6和血液中CD4/CD8比值可以作为观察IgAN扁桃体摘除术疗效的指标。 Objective To explore the significance of T lymphocyte subsets and urine Interleukin-6(uIL-6) in patients of IgA nephropathy after tonsillectomy.Methods 60 normal controls and 60 patients with IgA nephropathy were recruited.Levels of T lymphocyte subsets were determined by flow cytometry. uIL-6 was detected by enzyme-linked immunosorbent assay(ELISA).Results Compared with normal control group:The level of uIL-6 was significantly higher(P<0.01) and the quantities of CD4/CD8 were lower(P<0.01) before tonsillectomy.Comparing the patients before tonsillectomy with After tonsillectomy,The level of uIL-6 was gradually decrease in three month,At the same time,the quantities of CD4/CD8 were increase(P<0.01).Conclusion It suggested that tonsillectomy could reduce the immune stimulability obviously and help to resume for patients.Detecting the changes of T lymphocyte subsets and uIL-6 could be see as the markers for prognosis of the patients with IgA nephropathy after tonsillectomy.
出处 《医学检验与临床》 2007年第2期53-54,共2页 Medical Laboratory Science and Clinics
关键词 IGA肾病 T细胞亚群 IL-6 IgA nephropathy T lymphocyte subsets Interleukin-6
  • 相关文献

同被引文献44

  • 1李贵新,任思伟.C-反应蛋白在感染性疾病中的应用[J].医学检验与临床,2006,18(6). 被引量:1
  • 2余咏文,张强英.原发性肾病综合征患儿足量激素治疗前后血、尿白细胞介素-6检测的意义[J].实用儿科临床杂志,2006,21(5):286-287. 被引量:7
  • 3Mora C,Navarro JF.Inflammation and diabetic nephropathy[J].Curr Diab Rep,2006,6(6):463-468.
  • 4Giannakakis K,Feriozzi S,PerezM,et al.Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy[J].J Am Soc Nephrol,2007,18(12):3139-3146.
  • 5Coppo R,Amore A.Aberrantly glycosylation in IgA nephropathy(IgAN)[J].Kidney Int,2004,65(5):1544-1547.
  • 6Xu LX,Zhao MH.Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy[J].Kidney Int,2005,68(1):167-172.
  • 7Vuong MT,Lundberg S,Gunnarsson I,et al.Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy[J].Nephrol Dial Transplant,2009,24(10):3061-3067.
  • 8Harada K,Akai Y,Kurumatani N,et al.Prognositic value of urinary interleukin 6 in patients with IgA nephropathy:an 8-year follow-up study[J].Nephron,2002,92(4):824-826.
  • 9Horii Y,Muraguchi A,Iwano M,et al.Involrement of IL-6 in mesangial proliferative glome rulonephritis[J].J Immunol,1998,143(12):3949-3954.
  • 10Nakamura A,Suzuki T,Kohsaka T.Renal tubular function modulates urinary levels of interleukin-6[J].Nephron,1995,70(4):416-420.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部